PC Tel (NASDAQ:PCTI) Cut to “Hold” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research downgraded shares of PC Tel (NASDAQ:PCTI) from a buy rating to a hold rating in a research report report published on Friday, Zacks.com reports.

According to Zacks, “PCTEL designs, develops, and delivers wireless solutions. PCTEL’s products include wireless local area network software products that simplify installation, roaming, Internet access and billing. Its subsidiary, DTI, designs, develops and distributes software-defined receivers and receiver-based products that measure, monitor and optimize the performance of cellular and Wi-Fi networks. . MAXRAD designs, develops, manufactures, and distributes innovative antenna solutions that facilitate and simplify wireless communications. “

Separately, ValuEngine lowered shares of PC Tel from a buy rating to a hold rating in a research note on Tuesday, July 16th.

Shares of NASDAQ PCTI opened at $4.59 on Friday. The company has a market capitalization of $85.46 million, a price-to-earnings ratio of -19.96 and a beta of 0.04. PC Tel has a 12-month low of $3.88 and a 12-month high of $6.15. The business’s fifty day moving average is $4.76.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, August 8th will be paid a $0.055 dividend. This represents a $0.22 dividend on an annualized basis and a dividend yield of 4.79%. The ex-dividend date of this dividend is Wednesday, August 7th. PC Tel’s dividend payout ratio (DPR) is -73.91%.

Several institutional investors have recently added to or reduced their stakes in the business. Rutabaga Capital Management LLC MA lifted its stake in shares of PC Tel by 69.3% in the first quarter. Rutabaga Capital Management LLC MA now owns 941,895 shares of the Wireless communications provider’s stock valued at $4,719,000 after buying an additional 385,535 shares in the last quarter. BlackRock Inc. lifted its stake in shares of PC Tel by 3.4% in the fourth quarter. BlackRock Inc. now owns 532,307 shares of the Wireless communications provider’s stock valued at $2,284,000 after buying an additional 17,488 shares in the last quarter. Boston Partners lifted its stake in shares of PC Tel by 44.1% in the first quarter. Boston Partners now owns 193,541 shares of the Wireless communications provider’s stock valued at $970,000 after buying an additional 59,241 shares in the last quarter. Municipal Employees Retirement System of Michigan bought a new position in shares of PC Tel in the fourth quarter valued at $418,000. Finally, Hillsdale Investment Management Inc. bought a new position in shares of PC Tel in the second quarter valued at $414,000. 63.06% of the stock is currently owned by hedge funds and other institutional investors.

PC Tel Company Profile

PCTEL, Inc, together with its subsidiaries, delivers performance critical telecom solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company designs and manufactures precision antennas, which are used primarily in small cells, enterprise Wi-Fi access points, fleet management and transit systems, and in equipment and devices for the Industrial Internet of Things.

Featured Story: What is Call Option Volume?

Get a free copy of the Zacks research report on PC Tel (PCTI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for PC Tel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PC Tel and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Qorvo’s  “Buy” Rating Reaffirmed at Craig Hallum
Qorvo’s “Buy” Rating Reaffirmed at Craig Hallum
Pinterest  Rating Reiterated by Pivotal Research
Pinterest Rating Reiterated by Pivotal Research
Perficient  Price Target Raised to $44.00
Perficient Price Target Raised to $44.00
Immersion  Earns Buy Rating from Craig Hallum
Immersion Earns Buy Rating from Craig Hallum
Fortinet’s  Buy Rating Reaffirmed at Monness Crespi & Hardt
Fortinet’s Buy Rating Reaffirmed at Monness Crespi & Hardt
Maxim Group Reiterates “Buy” Rating for Coherus Biosciences
Maxim Group Reiterates “Buy” Rating for Coherus Biosciences


© 2006-2019 Ticker Report